Year archive

GlaxoSmithKline PLC — 2024 filings

All 332 regulatory filings released by GlaxoSmithKline PLC (GSK) in 2024, sourced directly from the official regulator.

332 Filings

2024 Period

2024 filings (332)

Filing	Released	Lang
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-12-23	English
Director/PDMR Shareholding Director's Dealing	2024-12-23	English
BLOCK LISTING APPLICATION Foreign Filer Report	2024-12-20	English
HEADLINE RESULTS FROM PHASE III FIRST TRIAL Foreign Filer Report	2024-12-20	English
Block Listing Application Share Issue/Capital Change	2024-12-20	English
Headline results from phase III FIRST trial Regulatory Filings	2024-12-20	English
JEMPERLI RECEIVES US FDA BREAKTHROUGH DESIGNATION Foreign Filer Report	2024-12-16	English
EMA GRANTS PRIME DESIGNATION FOR GSK 227 Foreign Filer Report	2024-12-16	English
JEMPERLI RECEIVES POSITIVE CHMP OPINION Foreign Filer Report	2024-12-16	English
Jemperli receives US FDA breakthrough designation Regulatory Filings	2024-12-16	English
EMA grants PRIME Designation for GSK’227 Regulatory Filings	2024-12-16	English
Jemperli receives positive CHMP opinion Regulatory Filings	2024-12-16	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-12-12	English
Director/PDMR Shareholding Director's Dealing	2024-12-12	English
OVERALL SURVIVAL DATA PRESENTED FOR BLENREP Foreign Filer Report	2024-12-09	English
Overall survival data presented for Blenrep Earnings Release Q4 2024	2024-12-09	English
BLENREP COMBINATION CHINA FILING ACCEPTANCE Foreign Filer Report	2024-12-09	English
NUCALA COPD SUBMISSION ACCEPTED BY US FDA Foreign Filer Report	2024-12-09	English
Blenrep combination China filing acceptance Regulatory Filings	2024-12-09	English
Nucala COPD submission accepted by US FDA Regulatory Filings	2024-12-09	English
ZHIFEI CHINA COLLABORATION REVISED AND EXTENDED Foreign Filer Report	2024-12-05	English
Zhifei China collaboration revised and extended Regulatory Filings	2024-12-05	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-12-02	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-12-02	English
Director/PDMR Shareholding Director's Dealing	2024-12-02	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-12-02	English
GSK LIQUID MENINGITIS VACCINE AUTHORISED IN EU Foreign Filer Report	2024-11-27	English
GSK liquid meningitis vaccine authorised in EU Regulatory Filings	2024-11-27	English
BLENREP COMBINATIONS ACCEPTED FOR US FDA REVIEW Foreign Filer Report	2024-11-25	English
Blenrep combinations accepted for US FDA review Regulatory Filings	2024-11-25	English
JAPAN APPROVES FIRST RSV VACCINE FOR ADULTS 50-59 Foreign Filer Report	2024-11-22	English
Japan approves first RSV vaccine for adults 50-59 Regulatory Filings	2024-11-22	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-11-19	English
Director/PDMR Shareholding Director's Dealing	2024-11-19	English
GLISTEN TRIAL OF LINERIXIBAT MEETS ENDPOINT Foreign Filer Report	2024-11-19	English
GLISTEN Trial of Linerixibat Meets Endpoint Regulatory Filings	2024-11-19	English
AMENDMENT TO THE SCHEDULE 13D Major Shareholding Notification	2024-11-15	English
GSK ANNOUNCES OVERALL SURVIVAL RESULTS FOR BLENREP Foreign Filer Report	2024-11-14	English
GSK announces overall survival results for Blenrep Legal Proceedings Report	2024-11-14	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2024-11-13	English
Block listing Interim Review Share Issue/Capital Change	2024-11-13	English
AMENDMENT TO FORM SC 13G Major Shareholding Notification	2024-11-12	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-11-12	English
Director/PDMR Shareholding Director's Dealing	2024-11-12	English
GSK PUBLISHES PROVISIONAL 2025 DIVIDEND DATES Foreign Filer Report	2024-11-12	English
GSK publishes provisional 2025 dividend dates Report Publication Announcement	2024-11-11	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-11-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-11-01	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-10-30	English
3RD QUARTER RESULTS Foreign Filer Report	2024-10-30	English
Director/PDMR Shareholding Director's Dealing	2024-10-30	English
3rd Quarter Results Earnings Release Q3 2024	2024-10-30	English
NEW POSITIVE AREXVY DATA IN YOUNGER ADULTS AT RISK Foreign Filer Report	2024-10-24	English
New positive Arexvy data in younger adults at risk Regulatory Filings	2024-10-24	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-10-17	English
Director/PDMR Shareholding Director's Dealing	2024-10-17	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-10-16	English
Director/PDMR Shareholding Director's Dealing	2024-10-16	English
FDA ACCEPTS NEW DRUG APPLICATION FOR GEPOTIDACIN Foreign Filer Report	2024-10-16	English
FDA accepts new drug application for gepotidacin Regulatory Filings	2024-10-16	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-10-15	English
POSITIVE RESULTS OF ANCHOR TRIALS OF DEPEMOKIMAB Foreign Filer Report	2024-10-15	English
Director/PDMR Shareholding Director's Dealing	2024-10-14	English
Positive results of ANCHOR trials of depemokimab Regulatory Filings	2024-10-14	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-10-11	English
Director/PDMR Shareholding Director's Dealing	2024-10-11	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-10-10	English
Director/PDMR Shareholding Director's Dealing	2024-10-10	English
ZANTAC (RANITIDINE) LITIGATION SETTLEMENTS Foreign Filer Report	2024-10-09	English
Zantac (ranitidine) litigation settlements Regulatory Filings	2024-10-09	English
POSITIVE EFFICACY DATA OF AREXVY OVER 3 SEASONS Foreign Filer Report	2024-10-08	English
Positive efficacy data of Arexvy over 3 seasons Regulatory Filings	2024-10-08	English
WVE - CHANGE IN BENEFICIAL OWNERSHIP Director's Dealing	2024-10-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-10-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-10-01	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-09-24	English
Director/PDMR Shareholding Director's Dealing	2024-09-24	English
POSITIVE EU OPINION FOR GSK LIQUID MENVEO VACCINE Foreign Filer Report	2024-09-24	English
Positive EU opinion for GSK liquid Menveo vaccine Legal Proceedings Report	2024-09-24	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-09-18	English
Statement: Zantac (ranitidine) litigation Legal Proceedings Report	2024-09-18	English
JAPAN FILING ACCEPTANCE: BLENREP MULTIPLE MYELOMA Foreign Filer Report	2024-09-17	English
Japan Filing Acceptance: Blenrep Multiple Myeloma Regulatory Filings	2024-09-17	English
CHINA BREAKTHROUGH THERAPY DESIGNATION FOR BLENREP Foreign Filer Report	2024-09-13	English
China Breakthrough Therapy Designation for Blenrep Legal Proceedings Report	2024-09-13	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-09-12	English
Director/PDMR Shareholding Director's Dealing	2024-09-12	English
POSITIVE MRNA FLU VACCINE PHASE II HEADLINE DATA Foreign Filer Report	2024-09-12	English
Positive mRNA flu vaccine Phase II headline data Earnings Release Q2 2024	2024-09-12	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-09-11	English
Statement: Zantac (ranitidine) litigation Regulatory Filings	2024-09-11	English
CHANGE OF REGISTERED OFFICE Foreign Filer Report	2024-09-11	English
Change of Registered Office Regulatory Filings	2024-09-11	English
UPDATE ON PHASE I/II THERAPEUTIC HSV VACCINE TRIAL Foreign Filer Report	2024-09-11	English
Update on phase I/II therapeutic HSV vaccine trial Regulatory Filings	2024-09-11	English
DEPEMOKIMAB LATE-BREAKING DATA PRESENTED AT ERS Foreign Filer Report	2024-09-09	English
Depemokimab late-breaking data presented at ERS Earnings Release FY 2024	2024-09-09	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-09-06	English
Director/PDMR Shareholding Director's Dealing	2024-09-06	English
POSITIVE PHASE III RESULTS FOR NUCALA IN COPD Foreign Filer Report	2024-09-06	English
Positive Phase III results for Nucala in COPD Regulatory Filings	2024-09-06	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-09-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-09-02	English
EMA APPROVAL ON AREXVY FOR 50-59 AT RISK Foreign Filer Report	2024-08-29	English
EMA approval on Arexvy for 50-59 at risk Regulatory Filings	2024-08-29	English
NUCALA APPROVED IN JAPAN FOR USE IN CRSWNP Foreign Filer Report	2024-08-28	English
SENKU DESIGNATION FOR BEPIROVIRSEN IN JAPAN Foreign Filer Report	2024-08-28	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-08-28	English
SENKU Designation for Bepirovirsen in Japan Regulatory Filings	2024-08-28	English
Nucala approved in Japan for use in CRSwNP Regulatory Filings	2024-08-28	English
Statement: Zantac (ranitidine) litigation Regulatory Filings	2024-08-28	English
Director/PDMR Shareholding Director's Dealing	2024-08-21	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-08-21	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-08-20	English
Director/PDMR Shareholding Director's Dealing	2024-08-20	English
B7-H3 ADC US FDA BREAKTHROUGH THERAPY DESIGNATION Foreign Filer Report	2024-08-20	English
B7-H3 ADC US FDA Breakthrough Therapy Designation Regulatory Filings	2024-08-20	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-08-16	English
Statement: Zantac (ranitidine) litigation Legal Proceedings Report	2024-08-16	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-08-12	English
Director/PDMR Shareholding Director's Dealing	2024-08-12	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-08-06	English
Statement: Zantac (ranitidine) litigation Legal Proceedings Report	2024-08-06	English
FDA EXPANDS JEMPERLI APPROVAL Foreign Filer Report	2024-08-02	English
FDA Expands Jemperli Approval Earnings Release Q2 2024	2024-08-02	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-08-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-08-01	English
2ND QUARTER RESULTS Foreign Filer Report	2024-07-31	English
Half-year Report Report Publication Announcement	2024-07-31	English
Half-year report Interim / Quarterly Report H1 2024	2024-07-31	English
2nd Quarter Results Earnings Release H1 2024	2024-07-31	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-07-29	English
CHMP POSITIVE OPINION ON AREXVY FOR 50-59 AT RISK Foreign Filer Report	2024-07-29	English
Statement: Zantac (ranitidine) litigation Regulatory Filings	2024-07-29	English
CHMP positive opinion on Arexvy for 50-59 at risk Legal Proceedings Report	2024-07-29	English
BLENREP EMA FILING ACCEPTANCE Foreign Filer Report	2024-07-19	English
Blenrep EMA Filing Acceptance Legal Proceedings Report	2024-07-19	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-07-18	English
Director/PDMR Shareholding Director's Dealing	2024-07-18	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-07-16	English
Director/PDMR Shareholding Director's Dealing	2024-07-16	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-07-15	English
Director/PDMR Shareholding Director's Dealing	2024-07-15	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-07-12	English
Director/PDMR Shareholding Director's Dealing	2024-07-12	English
GSK AND CUREVAC COLLABORATION RESTRUCTURED Foreign Filer Report	2024-07-03	English
GSK and CureVac collaboration restructured Regulatory Filings	2024-07-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-07-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-07-01	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-06-28	English
Statement: Zantac (ranitidine) litigation Regulatory Filings	2024-06-28	English
EMA VALIDATES JEMPERLI MARKETING AUTHORISATION Foreign Filer Report	2024-06-24	English
OMJJARA APPROVED IN JAPAN FOR MYELOFIBROSIS Foreign Filer Report	2024-06-24	English
Omjjara approved in Japan for myelofibrosis Legal Proceedings Report	2024-06-24	English
EMA validates Jemperli marketing authorisation Regulatory Filings	2024-06-24	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-06-21	English
Director/PDMR Shareholding Director's Dealing	2024-06-21	English
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE Regulatory Filings	2024-06-18	English
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE Regulatory Filings	2024-06-18	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-06-12	English
Director/PDMR Shareholding Director's Dealing	2024-06-12	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-06-11	English
Statement: Zantac (ranitidine) litigation Legal Proceedings Report	2024-06-11	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-06-10	English
Statement: Zantac (ranitidine) litigation Regulatory Filings	2024-06-10	English
FDA APPROVES AREXVY FOR ADULTS 50-59 AT RISK Foreign Filer Report	2024-06-10	English
FDA approves Arexvy for adults 50-59 at risk Regulatory Filings	2024-06-10	English
Delisting Announcement 2024 Delisting Announcement	2024-06-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-06-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-06-03	English
UNPRECEDENTED RESULTS IN JEMPERLI TRIAL CONTINUE Foreign Filer Report	2024-06-03	English
Unprecedented results in Jemperli trial continue Regulatory Filings	2024-06-03	English
ASCO POSITIVE BLENREP DREAMM-8 TRIAL RESULTS Foreign Filer Report	2024-06-03	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-06-03	English
ASCO positive Blenrep DREAMM-8 trial results Earnings Release Q2 2024	2024-06-03	English
Statement: Zantac (ranitidine) litigation Regulatory Filings	2024-06-03	English
SPECIALIZED DISCLOSURE REPORT Regulatory Filings	2024-05-31	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-05-24	English
Statement: Zantac (ranitidine) litigation Legal Proceedings Report	2024-05-24	English
POSITIVE PHASE III ASTHMA RESULTS FOR DEPEMOKIMAB Foreign Filer Report	2024-05-21	English
Positive phase III asthma results for depemokimab Earnings Release Q2 2024	2024-05-21	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-05-20	English
Director/PDMR Shareholding Director's Dealing	2024-05-20	English
CURRENT REPORT Foreign Filer Report	2024-05-17	English
GSK COMPLETES SALE OF SHARES IN HALEON PLC Foreign Filer Report	2024-05-17	English
GSK completes sale of shares in Haleon plc Regulatory Filings	2024-05-17	English
GSK announces intention to sell shares in Haleon Regulatory Filings	2024-05-16	English
2024 AGM Resolutions AGM Information	2024-05-15	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-05-14	English
Director/PDMR Shareholding Director's Dealing	2024-05-14	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2024-05-13	English
Block listing Interim Review Share Issue/Capital Change	2024-05-13	English
RESULT OF AGM Foreign Filer Report	2024-05-08	English
Result of AGM AGM Information	2024-05-08	English
BOARD COMMITTEE CHANGE Foreign Filer Report	2024-05-08	English
Board Committee Change Board/Management Information	2024-05-08	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-05-03	English
Director/PDMR Shareholding Director's Dealing	2024-05-03	English
1ST QUARTER RESULTS Foreign Filer Report	2024-05-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-05-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-05-01	English
1st Quarter Results Earnings Release Q1 2024	2024-05-01	English
Annual Financial Report Annual Report FY 2023	2024-04-30	English
Annual Financial Report Report Publication Announcement	2024-04-30	English
US FDA ACCEPTS NEW INDICATION FILING FOR JEMPERLI Foreign Filer Report	2024-04-24	English
US FDA accepts new indication filing for Jemperli Regulatory Filings	2024-04-24	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-04-19	English
Director/PDMR Shareholding Director's Dealing	2024-04-19	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-04-17	English
Director/PDMR Shareholding Director's Dealing	2024-04-17	English
RESULTS FROM LONG-TERM DATA RELATING TO SHINGRIX Foreign Filer Report	2024-04-17	English
GSK ANNOUNCES ADDITIONAL EAGLE-1 RESULTS Foreign Filer Report	2024-04-17	English
GSK announces additional EAGLE-1 results Regulatory Filings	2024-04-17	English
Results from long-term data relating to Shingrix Regulatory Filings	2024-04-17	English
AMENDMENT - DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-04-16	English
Amendment - Director/PDMR Shareholding Director's Dealing	2024-04-16	English
FDA ACCEPTS GSK MENINGITIS VACCINE CANDIDATE FILE Foreign Filer Report	2024-04-16	English
FDA accepts GSK meningitis vaccine candidate file Regulatory Filings	2024-04-16	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-04-15	English
Director/PDMR Shareholding Director's Dealing	2024-04-15	English
REPLACEMENT - TOTAL VOTING RIGHTS Foreign Filer Report	2024-04-04	English
Replacement - Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-04-04	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-04-02	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-04-02	English
AMENDMENT TO FORM SC 13D Major Shareholding Notification	2024-03-28	English
Director/PDMR Shareholding Director's Dealing	2024-03-26	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-03-26	English
F-3ASR Regulatory Filings	2024-03-25	English
GSK Proxy Form 2024 Proxy Solicitation & Information Statement	2024-03-25	English
GSK AGM Notice 2024 AGM Information	2024-03-25	English
NOTICE OF AGM Foreign Filer Report	2024-03-25	English
Notice of AGM AGM Information	2024-03-25	English
TRANSFER OF TREASURY SHARES Foreign Filer Report	2024-03-22	English
Transfer of Treasury Shares Share Issue/Capital Change	2024-03-22	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-03-22	English
Director/PDMR Shareholding Director's Dealing	2024-03-22	English
NEW PHASE III JEMPERLI DATA IN ENDOMETRIAL CANCER Foreign Filer Report	2024-03-18	English
New Phase III Jemperli data in endometrial cancer Earnings Release Q1 2024	2024-03-18	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-03-13	English
Director/PDMR Shareholding Director's Dealing	2024-03-13	English
BOARD COMMITTEE CHANGE Foreign Filer Report	2024-03-08	English
Board Committee Change Board/Management Information	2024-03-08	English
GSK ANNOUNCES POSITIVE BLENREP DREAMM-8 RESULTS Foreign Filer Report	2024-03-07	English
GSK announces positive Blenrep DREAMM-8 results Earnings Release FY 2023	2024-03-07	English
VIIV LAI VS ORAL SOC DATA IN ADHERENCE-CHALLENGED Foreign Filer Report	2024-03-06	English
ViiV LAI vs oral SOC data in adherence-challenged Regulatory Filings	2024-03-06	English
GSK ANNUAL REPORT 2023 ON FORM 20 F Foreign Filer Report	2024-03-05	English
IRANNOTICE Regulatory Filings	2024-03-05	English
GSK Annual Report 2023 on Form 20-F Report Publication Announcement FY 2023	2024-03-05	English
20-F Annual Report FY 2023	2024-03-05	English
NEW VIIV LA FORMULATION POTENTIAL 4-MONTH DOSING Foreign Filer Report	2024-03-05	English
New ViiV LA formulation potential 4-month dosing Regulatory Filings	2024-03-05	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-03-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-03-01	English
GSK PUBLISHES ANNUAL REPORT 2023 Foreign Filer Report	2024-03-01	English
GSK publishes Annual Report 2023 Report Publication Announcement	2024-03-01	English
2023 Annual Financial Report Annual Report (ESEF) FY 2023	2024-03-01	English
2023 Annual Financial Report Annual Report FY 2023	2024-03-01	English
DIRECTORATE CHANGE Foreign Filer Report	2024-02-29	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-02-29	English
Directorate Change Board/Management Information	2024-02-29	English
Statement: Zantac (ranitidine) litigation Legal Proceedings Report	2024-02-29	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-26	English
Director/PDMR Shareholding Director's Dealing	2024-02-26	English
GSK ANNOUNCES POSITIVE EAGLE-1 HEADLINE RESULTS Foreign Filer Report	2024-02-26	English
GSK announces positive EAGLE-1 headline results Regulatory Filings	2024-02-26	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-22	English
Director/PDMR Shareholding Director's Dealing	2024-02-22	English
VIIV LAI SUPERIOR TO ORALS IN ADHERENCE-CHALLENGED Foreign Filer Report	2024-02-21	English
ViiV LAI superior to orals in adherence-challenged Earnings Release Q4 2023	2024-02-21	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-20	English
Julie Brown - External Appointment Board/Management Information	2024-02-20	English
Director/PDMR Shareholding Director's Dealing	2024-02-19	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-15	English
Director/PDMR Shareholding Remuneration Information	2024-02-15	English
GSK COMPLETES ACQUISITION OF AIOLOS BIO Foreign Filer Report	2024-02-15	English
GSK completes acquisition of Aiolos Bio M&A Activity	2024-02-15	English
SC 13G/A Major Shareholding Notification	2024-02-13	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-13	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-13	English
Director/PDMR Shareholding - Replacement Director's Dealing	2024-02-13	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-13	English
Director/PDMR Shareholding Remuneration Information	2024-02-13	English
Director/PDMR Shareholding Remuneration Information	2024-02-13	English
Director/PDMR Shareholding Remuneration Information	2024-02-13	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-12	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-12	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-12	English
Director/PDMR Shareholding Director's Dealing	2024-02-12	English
Director/PDMR Shareholding Remuneration Information	2024-02-12	English
Director/PDMR Shareholding Remuneration Information	2024-02-12	English
US FDA FAST TRACK DESIGNATION FOR BEPIROVIRSEN Foreign Filer Report	2024-02-12	English
US FDA Fast Track designation for bepirovirsen Legal Proceedings Report	2024-02-12	English
AMENDMENT TO SC 13D Major Shareholding Notification	2024-02-09	English
AMENDMENT TO FORM SC 13G Major Shareholding Notification	2024-02-06	English
AMENDMENT TO FORM SC 13G Major Shareholding Notification	2024-02-06	English
FDA ACCEPTS AREXVY FILING FOR ADULTS 50-59 AT RISK Foreign Filer Report	2024-02-06	English
SHINGRIX 18+ AT RISK CHINA FILING REVIEW ACCEPTED Foreign Filer Report	2024-02-06	English
GSK PRESENTS POSITIVE DREAMM-7 PHASE III DATA Foreign Filer Report	2024-02-06	English
FDA accepts Arexvy filing for adults 50-59 at risk Regulatory Filings	2024-02-06	English
Shingrix 18+ at risk China filing review accepted Regulatory Filings	2024-02-06	English
GSK presents positive DREAMM-7 phase III data Regulatory Filings	2024-02-06	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-02-01	English
Director/PDMR Shareholding Director's Dealing	2024-02-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-02-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-02-01	English
STATEMENT: ZANTAC (RANITIDINE) LITIGATION Foreign Filer Report	2024-02-01	English
Statement: Zantac (ranitidine) litigation Regulatory Filings	2024-02-01	English
FINAL RESULTS Foreign Filer Report	2024-01-31	English
Final Results Earnings Release FY 2023	2024-01-31	English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Director's Dealing	2024-01-30	English
EMA ACCEPTS AREXVY FILING FOR ADULTS 50-59 AT RISK Foreign Filer Report	2024-01-29	English
EUROPEAN COMMISSION AUTHORISES OMJJARA IN THE EU Foreign Filer Report	2024-01-29	English
EMA accepts Arexvy filing for adults 50-59 at risk Regulatory Filings	2024-01-29	English
European Commission authorises Omjjara in the EU Regulatory Filings	2024-01-29	English
AMENDMENT TO FORM SC 13D Major Shareholding Notification	2024-01-19	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-01-19	English
Director/PDMR Shareholding Director's Dealing	2024-01-19	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-01-17	English
CURRENT REPORT Foreign Filer Report	2024-01-17	English
Director/PDMR Shareholding Director's Dealing	2024-01-17	English
GSK COMPLETES SALE OF SHARES IN HALEON PLC Foreign Filer Report	2024-01-17	English
GSK completes sale of shares in Haleon plc Share Issue/Capital Change	2024-01-17	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2024-01-16	English
GSK announces intention to sell shares in Haleon Regulatory Filings	2024-01-16	English
Director/PDMR Shareholding Director's Dealing	2024-01-16	English
NUCALA APPROVED IN CHINA FOR USE IN SEVERE ASTHMA Foreign Filer Report	2024-01-10	English
Nucala approved in China for use in severe asthma Regulatory Filings	2024-01-10	English
GSK ENTERS AGREEMENT TO ACQUIRE AIOLOS BIO Foreign Filer Report	2024-01-09	English
GSK enters agreement to acquire Aiolos Bio M&A Activity	2024-01-09	English
TOTAL VOTING RIGHTS Foreign Filer Report	2024-01-02	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2024-01-02	English

Filings by year

2026 229 filings
2025 709 filings
2024 332 filings
2023 304 filings
2022 416 filings
2021 350 filings
2020 337 filings
2019 337 filings
2018 352 filings
2017 355 filings
2016 527 filings
2015 397 filings
2014 569 filings
2013 727 filings
2012 472 filings
2011 400 filings
2010 157 filings
2009 1 filing